search

Active clinical trials for "Carcinoma"

Results 7791-7800 of 7825

MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii

Ovarian Cancer

Thyroid carcinoma on struma ovarii (TCSO) is a rare ovarian tumor, derivate from monodermic teratomas. It represents about 0.01% of overall ovarian tumours, and 5 to 10% of struma ovarii. The diagnosis is histologic and retrospective after pelvic surgery. Because of its rarity, the treatment of TCSO is not consensual and should be validated in multidisciplinary team involved in rare ovarian carcinoma. TCSO should be taken care of as a thyroid carcinoma, in case of relapse, with systemic treatment, as tyrosine kinase inhibitor (TKI), without any clinical trial proving this benefit. Indeed, molecular profiles and genomic expression is unknown, because of studies with few patients (less than 10) contrary to thyroid carcinomas with the TCGA genomic classification. The study purposes are the outcome of the patients after the first treatment and the comparison of the genomic profil in next generation sequencing (NGS) with TCGA thyroid carcinoma profile. Thus, the treatment could be tailored, confirming the same therapy as in thyroid carcinoma.

Unknown status4 enrollment criteria

Surgical Treatment of Pancreatic Metastases From Renal Cell Carcinoma

Surgical ProcedureDisease Free Survival1 more

Pancreatic metastases are a rare entity. In cases of metastatic renal carcinoma (RCC) it can present as isolated pancreatic metastasis, considering the possibility of surgical resection. Goals: Define survival after resection of pancreatic cancer metastases renal in a wide range of our country. Identify predictive survival factors Methods: Retrospective multicenter study in which cases of pancreatic resection due to renal cancer metastases.

Unknown status2 enrollment criteria

By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma...

Hepatocellular Carcinoma

Developing a radiomics model to predict the prognosis of patients with hepatocellular carcinoma after microwave ablation to provide advice for their treatment.

Unknown status8 enrollment criteria

Evaluating Mutations in MET and TP53 Among Patients Diagnosed With Squamous Cell Carcinoma

Squamous Cell Carcinoma of the LungSquamous Cell Carcinoma of the Head and Neck

This study focuses on advanced lung and head and neck SCC tumours, with adjacent normal lung tissues. Biopsies will be performed in National University Health System, Singapore (NUHS) as part of participants' standard care. Patient blood was also required for extraction of cell free DNA (cfDNA) and genomic DNA (gDNA). Patients' medical records will also be reviewed for the purpose of this study.

Unknown status6 enrollment criteria

Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma...

Squamous Cell Carcinoma of the OralClinically Node-Negative and Radiology

Squamous cell carcinoma of the VADS represents the majority of cancers in ENT. Metastatic lymph node involvement is an important prognostic factor. In N0 patients clinically and scanographically, the prevalence of cervical lymph node metastasis remains important. Only the anatomopathological analysis of cervical lymph node dissection confirms the presence of a micro-metastasis. However, new criteria of interpretation in nuclear medicine seem promising in the detection of lymph node lesions not detectable in traditional imaging. The main objective of this study is to study the positive predictive value (PPV) of CT scans in the anatomo-pathological analysis of N0 clinical and radiological or N + unilateral neck ganglia in patients with squamous cell carcinoma of the oral cavity.

Unknown status8 enrollment criteria

Liquid Biopsy-based Monitoring System for Relapse of HCC After Liver Transplantation: A Multi-center...

Hepatocellular Carcinoma

This study aims to develop a novel, reliable, liquid biopsy-based biomarker system for relapse of HCC associated with hepatitis B after liver transplantation.

Unknown status2 enrollment criteria

ACCEPTABILITY AND WRITING FREQUENCY OF ADVANCED DIRECTIVES IN ONCO-DERMATOLOGY PATIENTS

Advance DirectivesOncology5 more

The law about advance directives is evolving but, in France, few people write it. Te main endpoint of this research is to estimate the proportion of patients who have written their advance directives or considering doing so in onco-dermatologic population. If this rate remains low, some insights on the reasons will be able to be advanced looking at the point of view and opinion of patients about this topic. Seconds endpoints are : For patients against or not planning to write it, understand their reasons Estimate the proportion of patients requesting information and understand how they would like to receive it. Investigate a possible association between the stage of the oncological disease and the positioning of the patient concerning advance directives.

Unknown status7 enrollment criteria

Radio/Pathological Evaluation of Tongue Cancer Infiltration

Oral SquamousCell Carcinoma

The aim of the study is to assess the good correlation and prediction of the DOI for the post-operative pathological results and prognosis.

Unknown status6 enrollment criteria

A Prospective Multi-center Study on Using Sonazoid Diagnose Early Stage Endometrial Cancer

Endometrial Carcinoma Stage I

Sonazoid as a new generation of ultrasound contrast agent.This study based on the features of Sonazoid specific angiography and higher mechanical index, the role of Sonazoid in the early diagnosis of Endometrial carcinoma was explored.

Unknown status9 enrollment criteria

MRI in Ductal Carcinoma in Situ (DCIS)

Ductal Carcinomas

Compare the estimate of the lesional size in MRI to that in mammography, taking as a reference the definitive anatomo-pathological size

Unknown status3 enrollment criteria
1...779780781...783

Need Help? Contact our team!


We'll reach out to this number within 24 hrs